Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Steven Gourlay Insider Profile

4 Followers

Steven Gourlay, Managing Director & Chief Executive Officer at Actinogen Medical , holds 203.28M shares in Actinogen Medical (Ticker: ATGGF).

Steven Gourlay's Trading History

ATGGFActinogen Medical 		Jun 24, 2026Managing Director & Chief Executive OfficerUninformative Buy1.73M$5.89M
ATGGF
Insider Shares: 203.28M (555.23%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 24, 2026Uninformative BuyAU$1.73M38,000,000AU$0.05――
May 13, 2026Uninformative SellAU$91.60K2,442,647AU$0.04――
Mar 26, 2026Informative BuyAU$500.00K11,904,762AU$0.04-27.50%―
Mar 24, 2025Uninformative BuyAU$892.50K21,000,000AU$0.04――
Nov 04, 2024Informative BuyAU$1.00M33,333,334AU$0.03――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Steven Gourlay insider profile FAQ

What stocks does Steven Gourlay hold?
Steven Gourlay holds: ATGGF stocks.
What was Steven Gourlay’s latest transaction?
Steven Gourlay’s latest transaction was an Uninformative Buy of $1.73M.
What was Steven Gourlay's most profitable transaction?
Steven Gourlay’s most profitable transaction was an Informative Buy of ATGGF stock on March 26, 2026. The return on the trade was -27.50%.
What is Steven Gourlay's role in Actinogen Medical ?
Steven Gourlay's role in Actinogen Medical is Managing Director & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.